PCL Alverno to Implement Beckman Coulter's Expertise
By LabMedica International staff writers Posted on 25 Feb 2014 |
PCL Alverno Clinical Laboratories (Hammond, IN, USA) and Beckman Coulter Diagnostics (Brea, CA, USA) announced a partnership to create laboratories to better serve patients. Beckman Coulter was awarded an installation agreement by PLC Alverno with the aim of improving the clinical laboratory.
The contract includes a hematology extension of the laboratory network’s current only source agreement, a new Iris urinalysis agreement, AU chemistry instruments, DxI immunoassay instruments, and four automation lines.
PCL Alverno is a full service, community-based medical laboratory performing over 750 tests in both clinical and anatomic pathology. It is joint venture of two distinct Catholic healthcare systems: Presence Health (IL, USA) and Franciscan Alliance (IN, USA). PCL Alverno provides laboratory services for 26 hospitals in Indiana and Illinois and has a large reference lab for outreach work. Its modern state-of-the-art laboratory is a freestanding, local reference lab in its service area. PCL Alverno offers the personal customer service of a local laboratory with the style of a large reference laboratory. PCL Alverno's pathologists are part of the pathology practice of Pathology Consultants, Inc.
Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. PCL Alverno will modernize their laboratories with more than 150 new instruments beginning in 2014, implementing Beckman Coulter’s automation solutions and expertise in workflow processes.
“We are honored that PCL Alverno has chosen to partner with Beckman Coulter Diagnostics to provide solutions that deliver quality results through automation and standardized workflow processes in the laboratory,” said John Nosenzo, senior vice president of Global Customer Operations, Beckman Coulter Diagnostics. “This partnership demonstrates our shared commitment to patient care and allows us the opportunity to jointly advance and optimize the laboratory—the foundation of patient care.”
Related Links:
PCL Alverno Clinical Laboratories
Beckman Coulter Diagnostics
The contract includes a hematology extension of the laboratory network’s current only source agreement, a new Iris urinalysis agreement, AU chemistry instruments, DxI immunoassay instruments, and four automation lines.
PCL Alverno is a full service, community-based medical laboratory performing over 750 tests in both clinical and anatomic pathology. It is joint venture of two distinct Catholic healthcare systems: Presence Health (IL, USA) and Franciscan Alliance (IN, USA). PCL Alverno provides laboratory services for 26 hospitals in Indiana and Illinois and has a large reference lab for outreach work. Its modern state-of-the-art laboratory is a freestanding, local reference lab in its service area. PCL Alverno offers the personal customer service of a local laboratory with the style of a large reference laboratory. PCL Alverno's pathologists are part of the pathology practice of Pathology Consultants, Inc.
Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. PCL Alverno will modernize their laboratories with more than 150 new instruments beginning in 2014, implementing Beckman Coulter’s automation solutions and expertise in workflow processes.
“We are honored that PCL Alverno has chosen to partner with Beckman Coulter Diagnostics to provide solutions that deliver quality results through automation and standardized workflow processes in the laboratory,” said John Nosenzo, senior vice president of Global Customer Operations, Beckman Coulter Diagnostics. “This partnership demonstrates our shared commitment to patient care and allows us the opportunity to jointly advance and optimize the laboratory—the foundation of patient care.”
Related Links:
PCL Alverno Clinical Laboratories
Beckman Coulter Diagnostics
Latest Industry News
- Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
- Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance